Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer
Clinical trial NCT06062563 · UNKNOWN
Trial details
- NCT number
- NCT06062563
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-11
- Primary completion
- 2024-12-20
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.